Omicron-specific mRNA-based booster vaccine gets DCGI nod

[Hasan]

Omicron-specific mRNA-based booster vaccine gets DCGI nod DBT has facilitated establishing Gennova’s mRNA-based next-generation vaccine manufacturing for developing the platform technology from proof of concept till phase-I clinical trial of the prototype mRNA-based vaccine developed against the Wuhan strain